FDA Head Says Marijuana Has 'Benefit In Medical Conditions,' But Trump Administration Also Concer...

Thu, Feb 12

Perspectives

FDA Commissioner Marty Makary said the Trump administration is "very serious" about advancing medical cannabis access through rescheduling—but that it is also concerned about "side effects" like psychosis and "problems with learning and judgment." https://t.co/N0oYyVoyfM

4238

The head of the Food and Drug Administration (FDA) says that while the Trump administration is taking the potential harms of marijuana use among youth “very seriously,” it’s also important to...

Discover